Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial
- Resource Type
- Article
- Source
- In
European Neuropsychopharmacology June 2021 47:74-85 - Subject
- Language
- ISSN
- 0924-977X